Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer

被引:86
作者
Hou, L.
El-Omar, E. M.
Chen, J.
Grillo, P.
Rabkin, C. S.
Baccarelli, A.
Yeager, M.
Chanock, S. J.
Zatonski, W.
Sobin, L. H.
Lissowska, J.
Fraumeni, J. F., Jr.
Chow, W. H.
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
[2] Univ Aberdeen, Inst Med Sci, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
[3] IRCCS Osped Maggiore Policlin, Mol & Genet Epidemiol Ctr, Epidemiol Unit, Dept Occupat Clin & Prevent Med, I-20122 Milan, Italy
[4] Univ Milan, Dept Occupat Med, EPOCA Res Ctr Clin Occupat & Environm Epidemiol, I-20122 Milan, Italy
[5] NCI, Core Genotyping Facil, Ctr Adv Technol, Bethesda, MD 20892 USA
[6] Ctr Canc, Div Canc Epidemiol & Prevent, PL-02781 Warsaw, Poland
[7] M Sklodowska Curie Inst Oncol, PL-02781 Warsaw, Poland
[8] Armed Forces Inst Pathol, Dept Hepat & Gastrointestinal Pathol, Washington, DC 20306 USA
关键词
D O I
10.1093/carcin/bgl130
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Helicobacter pylori infection, the dominant risk factor for gastric cancers, has been shown to elicit T helper type 1 (Th1) polarized immunological responses. We conducted a population-based study of 305 gastric cancer cases and 427 age- and gender-matched controls in Warsaw, Poland, to evaluate the association with several variants in genes responsible for Th1-cell-mediated response. Genotyping was performed on genomic DNA by TaqMan(TM) assays to determine TNFA (-308 G > A, -417 G > A, -555 G > A, -1036 C > T, -1042 C > A, -1210 T > C), IL1A (-889 C > T), IFNGR2 (Ex7-128 T > C, Ex2-34 C > G and Ex2-16 A > G) and IL12A (IVS2-798 T > A, IVS2-701 C > A and Ex7+277 G > A) polymorphisms. We used unconditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for sex, age, education and smoking status. Out of six single nucleotide polymorphisms (SNPs) tested in TNFA, gastric cancer risk was significantly associated with the TNFA (-308 G > A) polymorphism, with ORs of 1.4 (95% CI: 1.0-2.0) for the G/A and 2.5 (95% CI: 1.3-4.9) for the A/A genotype carriers, when compared with the more frequent genotype (G/G) (P-trend < 0.001). Among the three tested SNPs in the IFNGR2 gene, only the Ex7-128C > T polymorphism was associated with increased risk, with ORs of 1.5 (95% CI: 1.0-2.3) for T/C and 1.7 (95% CI: 1.1-2.7) for C/C carriers when compared with T/T carriers (P-trend = 0.01). Subjects carrying both IFNGR2 Ex7-128 C/C and TNFA -308 A/A genotypes had the highest risk (OR = 5.5, 95% CI: 1.5-19.4), although the interaction was not statistically significant. IL1A (-889 C > T) and the three examined IL12A variants were unrelated to gastric cancer risk. Our findings suggest that two Th1-related polymorphisms (TNFA -308 A > G and IFNGR2 Ex7-128 C > T) may increase the risk of gastric cancer.
引用
收藏
页码:118 / 123
页数:6
相关论文
共 47 条
[1]
Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[2]
Interleukin 1β and tumour necrosis factor α Inhibit acid secretion in cultured rabbit parietal cells by multiple pathways [J].
Beales, ILP ;
Calam, J .
GUT, 1998, 42 (02) :227-234
[3]
Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context [J].
Chen, HM ;
Wilkins, LM ;
Aziz, N ;
Cannings, C ;
Wyllie, DH ;
Bingle, C ;
Rogus, J ;
Beck, JD ;
Offenbacher, S ;
Cork, MJ ;
Rafie-Kolpin, M ;
Hsieh, CM ;
Kornman, KS ;
Duff, GW .
HUMAN MOLECULAR GENETICS, 2006, 15 (04) :519-529
[4]
Chow WH, 1999, INT J CANCER, V81, P871, DOI 10.1002/(SICI)1097-0215(19990611)81:6&lt
[5]
871::AID-IJC6&gt
[6]
3.0.CO
[7]
2-#
[8]
Helicobacter pylori, T cells and cytokines:: the "dangerous liaisons" [J].
D'Elios, MM ;
Amedei, A ;
Benagiano, M ;
Azzurri, A ;
Del Prete, G .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2005, 44 (02) :113-119
[9]
Gastric autoimmunity:: the role of Helicobacter pylori and molecular mimicry [J].
D'Elios, MM ;
Appelmelk, BJ ;
Amedei, A ;
Bergman, MP ;
Del Prete, G .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (07) :316-323
[10]
Daly Ann K, 2002, Am J Pharmacogenomics, V2, P13, DOI 10.2165/00129785-200202010-00002